cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25345/c5g73771x
title: MassIVE Reanalysis RMSV000000388.7 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080701/PXD000612 [14 out of 27] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5bk16s71
title: MassIVE Reanalysis RMSV000000433.2 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080836/PXD003700 [4 out of 14] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c56t0h04s
title: MassIVE Reanalysis RMSV000000444.2 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080868/PXD003523 [4 out of 14] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5319s599
title: MassIVE Reanalysis RMSV000000377.3 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080851/PXD001736 [1 out of 8] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.19130060
title: Supplementary Material for: BILIARY SPHINCTEROTOMY ALONE VS BILIARY STENT WITH OR WITHOUT BILIARY SPHINCTEROTOMY FOR THE MANAGEMENT OF POST-CHOLECYSTECTOMY BILE LEAK: A SYTEMATIC REVIEW AND META-ANALYSIS

description: BACKGROUND: Endoscopic therapy with ERCP is considered the first line treatment in the management of post-cholecystectomy bile leak (PCBL). Currently there is no consensus on the most effective endoscopic intervention for PCBL. Hence, we performed a systematic review and meta-analysis to compare the effectiveness and safety of the two interventional groups (biliary sphincterotomy [BS] alone vs biliary stent ± BS) in management of PCBL. METHODS: We conducted a comprehensive search of multiple electronic databases and conference proceedings (from inception through January 2021). The primary outcome was to compare the pooled rate of clinical success between the 2 groups. The secondary outcome was to estimate the pooled rate of adverse events. RESULTS: The pooled rate of clinical success with BS alone (5 studies, 299 patients) was 88% (95% CI: 84%- 92%, I2: 0%) and for biliary stent ± BS (5 studies, 864 patients) was 97% (CI: 93%-100%, I2: 79%). The rate of clinical success in biliary stent ± BS group was significantly higher than BS alone group (OR: 3.91 95% CI: 2.29-6.69, p&lt;0.001, I2: 13%). The rate of adverse events was numerically lower in biliary stent ± BS group compared to BS alone (3 studies; OR: 0.65 95% CI: 0.41-1.03, p=0.07) without statistical significance. Low heterogeneity was noted in the analysis. CONCLUSIONS: Biliary stent ± BS is more effective in endoscopic management of PCBL compared to BS alone. This may be related to inter-endoscopist variation in completeness of sphincterotomy and post sphincterotomy edema, which can influence the preferential trans-papillary flow of bile.
DOI: 10.6084/m9.figshare.19130060.v1
title: Supplementary Material for: BILIARY SPHINCTEROTOMY ALONE VS BILIARY STENT WITH OR WITHOUT BILIARY SPHINCTEROTOMY FOR THE MANAGEMENT OF POST-CHOLECYSTECTOMY BILE LEAK: A SYTEMATIC REVIEW AND META-ANALYSIS

description: BACKGROUND: Endoscopic therapy with ERCP is considered the first line treatment in the management of post-cholecystectomy bile leak (PCBL). Currently there is no consensus on the most effective endoscopic intervention for PCBL. Hence, we performed a systematic review and meta-analysis to compare the effectiveness and safety of the two interventional groups (biliary sphincterotomy [BS] alone vs biliary stent ± BS) in management of PCBL. METHODS: We conducted a comprehensive search of multiple electronic databases and conference proceedings (from inception through January 2021). The primary outcome was to compare the pooled rate of clinical success between the 2 groups. The secondary outcome was to estimate the pooled rate of adverse events. RESULTS: The pooled rate of clinical success with BS alone (5 studies, 299 patients) was 88% (95% CI: 84%- 92%, I2: 0%) and for biliary stent ± BS (5 studies, 864 patients) was 97% (CI: 93%-100%, I2: 79%). The rate of clinical success in biliary stent ± BS group was significantly higher than BS alone group (OR: 3.91 95% CI: 2.29-6.69, p&lt;0.001, I2: 13%). The rate of adverse events was numerically lower in biliary stent ± BS group compared to BS alone (3 studies; OR: 0.65 95% CI: 0.41-1.03, p=0.07) without statistical significance. Low heterogeneity was noted in the analysis. CONCLUSIONS: Biliary stent ± BS is more effective in endoscopic management of PCBL compared to BS alone. This may be related to inter-endoscopist variation in completeness of sphincterotomy and post sphincterotomy edema, which can influence the preferential trans-papillary flow of bile.
DOI: 10.25345/c5z892j49
title: MassIVE Reanalysis RMSV000000399.2 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080692/PXD002516 [7 out of 10] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5pr7mx7w
title: MassIVE Reanalysis RMSV000000366.13 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000086387 A Quantitative Proteome Map of the Human Body, TMT10 MS3 [Mixture: 28] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5th8br05
title: MassIVE Reanalysis RMSV000000592.6 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000083508 29 tissues, tonsil Chymotrypsin_CID_OrbitrapFusionLumos [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5fb4wq2n
title: MassIVE Reanalysis RMSV000000584.21 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000079514/PXD000561 [19 out of 41], Gut [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5k06x44z
title: MassIVE Reanalysis RMSV000000382.8 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080596/PXD004242 [19 out of 51] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c59k45w9r
title: MassIVE Reanalysis RMSV000000441.3 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080814/PXD003668 [2 out of 10] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.48370/ofd/rxooas
title: Eucnemis capucina (Ahrens, 1812), C-587

description: Coleoptera collection
DOI: 10.25345/c55t3g34j
title: MassIVE Reanalysis RMSV000000382.7 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000080596/PXD004242 [5 out of 51] [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5222r90q
title: MassIVE Reanalysis RMSV000000584.22 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000079514/PXD000561 Part 2 [50 out of 85], Esophagus [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5x921n53
title: MassIVE Reanalysis RMSV000000584.23 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000079514/PXD000561 [7 out of 41], Spinal cord [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5sj19v3x
title: MassIVE Reanalysis RMSV000000451.3 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000083957 Enrichment strategy for searching missing protein, low molecular weight proteins, glycine SDS-PAGE [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5nv99f00
title: MassIVE Reanalysis RMSV000000586.11 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000079526/PXD000865 [13 out of 46], Vulva [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.19390871
title: Supplementary Material for: COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents

description: <b><i>Background:</i></b> It is not known if widespread vaccination can prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in subpopulations at high risk, like older adults in nursing homes (NH). <b><i>Objective:</i></b> The objective of the study was to know if coronavirus disease 2019 (COVID-19) outbreaks can occur in NH with high vaccination coverage among its residents. <b><i>Methods:</i></b> We identified, using national professional networks, NH that suffered COVID-19 outbreaks despite having completed a vaccination campaign, and asked them to send data, using predefined collecting forms, on the number of residents exposed, their vaccination status and the number, characteristics, and evolution of patients infected. The main outcome was to identify outbreaks occurring in NH with high vaccine coverage. Secondary outcomes were residents’ risk of being infected, developing severe disease, or dying from COVID-19 during the outbreak. SARS-CoV-2 infection was defined by a positive reverse transcriptase-polymerase chain reaction. All residents were serially tested whenever cases appeared in a facility. Unadjusted secondary attack rates, relative risks, and vaccine effectiveness during the outbreak were estimated. <b><i>Results:</i></b> We identified 31 NH suffering an outbreak during March–April 2021, of which 27 sent data, cumulating 1,768 residents (mean age 88.4, 73.4% women, 78.2% fully vaccinated). BNT162b2 was the vaccine employed in all NH. There were 365 cases of SARS-CoV-2 infection. Median secondary attack rates were 20.0% (IQR 4.4%–50.0%) among unvaccinated residents and 16.7% (IQR 9.5%–29.2%) among fully vaccinated ones. Severe cases developed in 42 of 80 (52.5%) unvaccinated patients, compared with 56 of 248 (22.6%) fully vaccinated ones (relative risks [RR] 4.17, 95% CI: 2.43–7.17). Twenty of the unvaccinated patients (25.0%) and 16 of fully vaccinated ones (6.5%) died from COVID-19 (RR 5.11, 95% CI: 2.49–10.5). Estimated vaccine effectiveness during the outbreak was 34.5% (95% CI: 18.5–47.3) for preventing SARS-CoV-2 infection, 71.8% (58.8–80.7) for preventing severe disease, and 83.1% (67.8–91.1) for preventing death. <b><i>Conclusions:</i></b> Outbreaks of COVID-19, including severe cases and deaths, can still occur in NH despite full vaccination of a majority of residents. Vaccine remains highly effective, however, for preventing severe disease and death. Prevention and control measures for SARS-CoV-2 should be maintained in NH at periods of high incidence in the community.
DOI: 10.25345/c5j38km71
title: MassIVE Reanalysis RMSV000000451.4 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000083957 Enrichment strategy for searching missing protein, ubiquitome HCD, 2 PTMs/peptide [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5db7vt4c
title: MassIVE Reanalysis RMSV000000422.2 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of MSV000083983 Human_Testis_QE-HF, tricine SDS-PAGE files only [launched by cfca6e4ba8934e65aa11617b56091339]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.14457/cu.the.2008.1618
title: Determination of partition coefficients and dissociation constants of neutral weak acid in single titration

description: The three parameters, equivalent point or purity, dissociation constant and partition coefficient, were calculated applying multiple linear regression equation to simulated titration data by three computer programs (Excel®2007, Wessa (2009) and MINITAB®15) and all obtained results were compared. In many cases, analysis of simulated data yield inaccurate results, possibly due to programming algorithms. The two modified simple linear regression equations were derived for determination of equivalent point of titration and partition coefficient using titration data from dual phase titration. The two modified simple linear equations, together with Gran equation, can be employed to determine equivalent point or purity, dissociation constant and partition coefficient of weak monoprotic acid from one single titration experiment. The obtained parameters of five weak monoprotic acids, acetic acid, benzoic acid, 2-methoxybenzoic acid, salicylic acid and m-toluic acid, were determined using reference method and potentiometric methods. These results suggest that this method is effective and useful as its saving time.
DOI: 10.14457/cu.the.2008.1619
title: Development of glycolic acid niosome for skin delivery

description: Glycolic acid (GA) is popularly used in many cosmetic products as exfoliant and moisturizer. Unfortunately high glycolic acid concentration has high potential for skin irritation. The aim of this study was to prepare and characterize glycolic acid niosomes in order to increase skin delivery and reduce its irritation effect. For this purpose niosomes which contain of various classes of nonionic surfactant such as polyoxyethylene alkyl ethers (Brij®52 and Brij®76), sorbitan fatty acid esters (Span®20, Span®40, and Span®60), glyceryl distearate (GDS), and sucrose laurate ester (L-595®) were prepared by sonication method that was devoid of organic solvent. Characterization of GA niosomes was then performed. Morphology of vesicle was observed by optical and polarized light microscopy. Size and size distribution were characterized by dynamic light scattering. Entrapment of glycolic acid was evaluated by ultracentrifugation and HPLC method. Physical stability was investigated by the change of morphology, size and size distribution, entrapment, and pH in each formulation. Release of GA through cellulose acetate membrane and permeation of GA across newborn pig skin were studied using modified Franz diffusion cells. Furthermore, irritation potential of niosomes was investigated by sheep red blood cell test. The results revealed that niosomes completely formed spherical shape. Niosomal size and entrapment depended on niosomal compositions and surfactant structure. All niosomal formulations were physical stable within two months of storage at ambient temperature. The release of GA from some selected niosomal systems was sustained and followed the first order kinetics. The release rate constants depended on entrapment and thermodynamic state of bilayers. Most of niosomal formulations enhanced GA permeability across the skin based on surfactant structure and thermodynamic state of bilayers. Moreover, all GA niosomes much reduced irritation than that from aqueous solution and depended on niosomal compositions, surfactant structure, and thermodynamic state of bilayers. Consequently, the results of this study indicate that niosomes could be developed as topical delivery of water soluble substances such as glycolic acid for cosmetic uses.